CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

Phase 3
Related Companies

Read the original article

Published by STAT News on September 2, 2026 8:37 PM

Read Original